wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39646209-F6253091-EA7D-4DE6-9BDB-5E97F99C2F5C
Q39646209-F6253091-EA7D-4DE6-9BDB-5E97F99C2F5C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39646209-F6253091-EA7D-4DE6-9BDB-5E97F99C2F5C
The in vivo mechanism of action of CD20 monoclonal antibodies depends on local tumor burden.
P2860
Q39646209-F6253091-EA7D-4DE6-9BDB-5E97F99C2F5C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39646209-F6253091-EA7D-4DE6-9BDB-5E97F99C2F5C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e8542dc8f6629b1da0a206e1429a66d1aff8aa7d
P2860
Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia.